Home Testicular adrenal rest tumors in patients with congenital adrenal hyperplasia: 6 years of follow-up
Article
Licensed
Unlicensed Requires Authentication

Testicular adrenal rest tumors in patients with congenital adrenal hyperplasia: 6 years of follow-up

  • Gabriela Werneck EMAIL logo , Enda M.R. Rodrigues , Rafael M. Mantovani , Jovita S.S. Lane and Ivani N. Silva
Published/Copyright: May 10, 2019

Abstract

Background

Testicular adrenal rest tumors (TARTs) leading to primary gonadal failure are the main etiology of infertility in congenital adrenal hyperplasia (CAH). We aimed at identifying the evolution of TART and related findings in young CAH patients.

Methods

Twelve male patients (3–23 years old) with 21-hydroxilase deficiency (11 with classic salt-wasting form) were included. Testicular ultrasonography (US) was performed in two moments, by a single blinded specialist in pediatric diagnostic imaging. Tumor progression was classified according to the Response Evaluation Criteria in Solid Tumors (RECIST). The clinical and laboratory data were retrieved from medical records. Serum 17-OH-progesterone (17OHP) and androstenedione concentrations were evaluated during the whole period of follow-up, from the CAH diagnosis. A logistic regression model with repeated measures was developed for the analysis.

Results

The prevalence of TART was 41.6% (n = 5) in the initial US evaluation and 66.6% (n = 8) after 6 years of follow-up. Tumor progression was detected in 4 of the 5 patients, and 1 presented with a stable tumor. Three patients presented with new tumors in the second evaluation. Most of the patients (n = 11) were pubertal, including a 7-year-old child with TART who presented with central precocious puberty. At regression analysis, it was observed that an inadequate hormonal control led to a 16 times greater chance of a patient to present with TART (OR = 16.08; confidence interval [CI] 95% = 2.38–108.81; p = 0.004).

Conclusions

We found a high prevalence of progressive TART in young pubertal subjects. US testicular screening should help in improving therapeutic optimization in CAH patients to reduce future impairment in fertility.


Corresponding author: Dr. Gabriela Werneck, Divisão de Endocrinologia Infantil e do Adolescente – Departamento de Pediatria, Faculdade de Medicina/Hospital das Clínicas, Universidade Federal de Minas Gerais, Av. Alfredo Balena 190, s/267, 30130-100, Belo Horizonte, MG, Brazil, Phone: +55-31-34099773

Acknowledgments

The authors wish to thank all the patients involved in the study and the personal staff from the Department of Pediatric Endocrinology for their contibution and assistance in all the steps of the study.

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: None declared.

  3. Employment or leadership: None declared.

  4. Honorarium: None declared.

  5. Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

References

1. Claahsen-van der Grinten HL, Otten BJ, Stikkelbroeck MM, Sweep FC, Hermus AR. Testicular adrenal rest tumours in congenital adrenal hyperplasia. Best Pract Res Clin Endocrinol Metab 2009;23:209–20.10.1016/j.beem.2008.09.007Search in Google Scholar PubMed

2. Claahsen-van der Grinten HL, Dehzad F, Kamphuis-van Ulzen K, de Korte CL. Increased prevalence of testicular adrenal rest tumours during adolescence in congenital adrenal hyperplasia. Horm Res Paediatr 2014;82:238–44.10.1159/000365570Search in Google Scholar PubMed

3. Speiser PW, Arlt W, Auchus RJ, Baskin LS, Conway GS, et al. Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2018;103:4043–88.10.1210/jc.2018-01865Search in Google Scholar PubMed PubMed Central

4. White PC, Speiser PW. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocr Rev 2000;21:245–91.Search in Google Scholar

5. Engels M, Gehrmann K, Falhammar H, Webb EA, Nordenstrom A, et al. Gonadal function in adult male patients with congenital adrenal hyperplasia. Eur J Endocrinol 2018;178:285–94.10.1530/EJE-17-0862Search in Google Scholar PubMed

6. Reisch N, Rottenkolber M, Greifenstein A, Krone N, Schmidt H, et al. Testicular adrenal rest tumors develop independently of long-term disease control: a longitudinal analysis of 50 adult men with congenital adrenal hyperplasia due to classic 21-hydroxylase deficiency. J Clin Endocrinol Metab 2013;98:E1820–6.10.1210/jc.2012-3181Search in Google Scholar PubMed

7. Fernandes VO, Barros AI, Quidute AR, Montenegro AP, Fontenele EG, et al. [Bilateral testicular tumors caused by congenital adrenal rest hyperplasia]. Arq Bras Endocrinol Metabol 2009;53:1052–8.10.1590/S0004-27302009000800022Search in Google Scholar

8. Stikkelbroeck NM, Suliman HM, Otten BJ, Hermus AR, Blickman JG, et al. Testicular adrenal rest tumours in postpubertal males with congenital adrenal hyperplasia: sonographic and MR features. Eur Radiol 2003;13:1597–603.10.1007/s00330-002-1786-3Search in Google Scholar PubMed

9. Marshall WA, Tanner JM. Variations in the pattern of pubertal changes in boys. Arch Dis Child 1970;45:13–23.10.1136/adc.45.239.13Search in Google Scholar PubMed PubMed Central

10. Cordeiro GV, Silva IN, Goulart EM, Chagas AJ, Kater CE. Final height in congenital adrenal hyperplasia: the dilemma of hypercortisolism versus hyperandrogenism. Arq Bras Endocrinol Metabol 2013;57:126–31.10.1590/S0004-27302013000200005Search in Google Scholar

11. Coley B. Caffey’s pediatric diagnostic imaging, 12th ed. Cincinatti: Elsevier/Saunders, 2013:1784.Search in Google Scholar

12. Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 2009;45:228–47.10.1016/j.ejca.2008.10.026Search in Google Scholar PubMed

13. Bouman A, Hulsbergen-van de Kaa C, Claahsen-van der Grinten HL. Prevalence of testicular adrenal rest tissue in neonates. Horm Res Paediatr 2011;75:90–3.10.1159/000316531Search in Google Scholar PubMed

14. Stikkelbroeck NM, Otten BJ, Pasic A, Jager GJ, Sweep CG, et al. High prevalence of testicular adrenal rest tumors, impaired spermatogenesis, and Leydig cell failure in adolescent and adult males with congenital adrenal hyperplasia. J Clin Endocrinol Metab 2001;86:5721–8.10.1210/jcem.86.12.8090Search in Google Scholar PubMed

15. Fitoz S, Atasoy C, Adiyaman P, Berberoglu M, Erden I, et al. Testicular adrenal rests in a patient with congenital adrenal hyperplasia: US and MRI features. Comput Med Imaging Graph 2006;30:465–8.10.1016/j.compmedimag.2006.09.012Search in Google Scholar PubMed

16. Rutgers JL, Young RH, Scully RE. The testicular “tumor” of the adrenogenital syndrome. A report of six cases and review of the literature on testicular masses in patients with adrenocortical disorders. Am J Surg Pathol 1988;12:503–13.10.1097/00000478-198807000-00001Search in Google Scholar

17. Hatano O, Takakusu A, Nomura M, Morohashi K. Identical origin of adrenal cortex and gonad revealed by expression profiles of Ad4BP/SF-1. Genes Cells 1996;1:663–71.10.1046/j.1365-2443.1996.00254.xSearch in Google Scholar PubMed

18. Mouritsen A, Jorgensen N, Main KM, Schwartz M, Juul A. Testicular adrenal rest tumours in boys, adolescents and adult men with congenital adrenal hyperplasia may be associated with the CYP21A2 mutation. Int J Androl 2010;33:521–7.10.1111/j.1365-2605.2009.00967.xSearch in Google Scholar PubMed

19. Hamwi GJ, Gwinup G, Mostow JH, Besch PK. Activation of testicular adrenal rest tissue by prolonged excessive ACTH production. J Clin Endocrinol Metab 1963;23:861–9.10.1210/jcem-23-9-861Search in Google Scholar PubMed

20. Stikkelbroeck NM, Hermus AR, Suliman HM, Jager GJ, Otten BJ. Asymptomatic testicular adrenal rest tumours in adolescent and adult males with congenital adrenal hyperplasia: basal and follow-up investigation after 2.6 years. J Pediatr Endocrinol Metab 2004;17:645–53.10.1515/JPEM.2004.17.4.645Search in Google Scholar

21. Smeets EE, Span PN, van Herwaarden AE, Wevers RA, Hermus AR, et al. Molecular characterization of testicular adrenal rest tumors in congenital adrenal hyperplasia: lesions with both adrenocortical and Leydig cell features. J Clin Endocrinol Metab 2015;100:E524–30.10.1210/jc.2014-2036Search in Google Scholar PubMed

22. Reisch N, Scherr M, Flade L, Bidlingmaier M, Schwarz HP, et al. Total adrenal volume but not testicular adrenal rest tumor volume is associated with hormonal control in patients with 21-hydroxylase deficiency. J Clin Endocrinol Metab 2010;95:2065–72.10.1210/jc.2009-1929Search in Google Scholar PubMed

23. Engels M, Span PN, Mitchell RT, Heuvel J, Marijnissen-van Zanten MA, et al. GATA transcription factors in testicular adrenal rest tumours. Endocr Connect 2017;6:866–75.10.1530/EC-17-0215Search in Google Scholar PubMed PubMed Central

24. Kang MJ, Kim JH, Lee SH, Lee YA, Shin CH, et al. The prevalence of testicular adrenal rest tumors and associated factors in postpubertal patients with congenital adrenal hyperplasia caused by 21-hydroxylase deficiency. Endocr J 2011;58:501–8.10.1507/endocrj.K11E-034Search in Google Scholar

25. Reisch N, Flade L, Scherr M, Rottenkolber M, Pedrosa Gil F, et al. High prevalence of reduced fecundity in men with congenital adrenal hyperplasia. J Clin Endocrinol Metab 2009;94:1665–70.10.1210/jc.2008-1414Search in Google Scholar PubMed

26. Claahsen-van der Grinten HL, Otten BJ, Sweep FC, Span PN, Ross HA, et al. Testicular tumors in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency show functional features of adrenocortical tissue. J Clin Endocrinol Metab 2007;92:3674–80.10.1210/jc.2007-0337Search in Google Scholar PubMed

27. Mendes-Dos-Santos CT, Martins DL, Guerra-Junior G, Baptista MT, de-Mello MP, et al. Prevalence of testicular adrenal rest tumor and factors associated with its development in congenital adrenal hyperplasia. Horm Res Paediatr 2018;90:1–8.10.1159/000492082Search in Google Scholar PubMed

28. Claahsen-van der Grinten HL, Sweep FC, Blickman JG, Hermus AR, Otten BJ. Prevalence of testicular adrenal rest tumours in male children with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Eur J Endocrinol 2007;157:339–44.10.1530/EJE-07-0201Search in Google Scholar PubMed

29. Aycan Z, Bas VN, Cetinkaya S, Yilmaz Agladioglu S, Tiryaki T. Prevalence and long-term follow-up outcomes of testicular adrenal rest tumours in children and adolescent males with congenital adrenal hyperplasia. Clin Endocrinol 2013;78:667–72.10.1111/cen.12033Search in Google Scholar PubMed

30. Claahsen-van der Grinten HL, Stikkelbroeck NM, Sweep CG, Hermus AR, Otten BJ. Fertility in patients with congenital adrenal hyperplasia. J Pediatr Endocrinol Metab 2006;19:677–85.10.1515/JPEM.2006.19.5.677Search in Google Scholar PubMed

31. Martinez-Aguayo A, Rocha A, Rojas N, Garcia C, Parra R, et al. Testicular adrenal rest tumors and Leydig and Sertoli cell function in boys with classical congenital adrenal hyperplasia. J Clin Endocrinol Metab 2007;92:4583–9.10.1210/jc.2007-0383Search in Google Scholar PubMed

32. Falhammar H, Nystrom HF, Ekstrom U, Granberg S, Wedell A, et al. Fertility, sexuality and testicular adrenal rest tumors in adult males with congenital adrenal hyperplasia. Eur J Endocrinol 2012;166:441–9.10.1530/EJE-11-0828Search in Google Scholar PubMed PubMed Central

33. Claahsen-van der Grinten HL, Otten BJ, Sweep FC, Hermus AR. Repeated successful induction of fertility after replacing hydrocortisone with dexamethasone in a patient with congenital adrenal hyperplasia and testicular adrenal rest tumors. Fertil Steril 2007;8:705.e5–8.10.1016/j.fertnstert.2006.11.148Search in Google Scholar PubMed

34. King TF, Lee MC, Williamson EE, Conway GS. Experience in optimizing fertility outcomes in men with congenital adrenal hyperplasia due to 21 hydroxylase deficiency. Clin Endocrinol 2016;84:830–6.10.1111/cen.13001Search in Google Scholar PubMed

35. Giacaglia LR, Mendonca BB, Madureira G, Melo KF, Suslik CA, et al. Adrenal nodules in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency: regression after adequate hormonal control. J Pediatr Endocrinol Metab 2001;14:415–9.10.1515/JPEM.2001.14.4.415Search in Google Scholar

36. Avila NA, Premkumar A, Shawker TH, Jones JV, Laue L, et al. Testicular adrenal rest tissue in congenital adrenal hyperplasia: findings at Gray-scale and color Doppler US. Radiology 1996;198:99–104.10.1148/radiology.198.1.8539414Search in Google Scholar PubMed

37. Chaudhari M, Johnson EK, DaJusta D, Nahata L. Testicular adrenal rest tumor screening and fertility counseling among males with congenital adrenal hyperplasia. J Pediatr Urol 2018;14:155.e1–6.10.1016/j.jpurol.2017.11.011Search in Google Scholar PubMed

38. Wang Z, Yang Z, Wang W, Chen LD, Huang Y, et al. Diagnosis of testicular adrenal rest tumors on ultrasound: a retrospective study of 15 cases report. Medicine (Baltimore) 2015;94:e1471.10.1097/MD.0000000000001471Search in Google Scholar PubMed PubMed Central

39. Kim MS, Goodarzian F, Keenan MF, Geffner ME, Koppin CM, et al. Testicular adrenal rest tumors in boys and young adults with congenital adrenal hyperplasia. J Urol 2017;197(3 Pt 2):931–6.10.1016/j.juro.2016.09.072Search in Google Scholar PubMed PubMed Central

40. Yu MK, Jung MK, Kim KE, Kwon AR, Chae HW, et al. Clinical manifestations of testicular adrenal rest tumor in males with congenital adrenal hyperplasia. Ann Pediatr Endocrinol Metab 2015;20:155–61.10.6065/apem.2015.20.3.155Search in Google Scholar PubMed PubMed Central

Received: 2018-11-26
Accepted: 2019-03-14
Published Online: 2019-05-10
Published in Print: 2019-05-27

©2019 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Reviews
  3. Using height-corrected definition of metabolic syndrome in children and adolescents
  4. Association between early antibiotic exposure and risk of childhood weight gain and obesity: a systematic review and meta-analysis
  5. Original Articles
  6. Carbonated beverage consumption is associated with lower C-peptide in adolescents
  7. Low levels of cardiorespiratory fitness and abdominal resistance are associated with metabolic risk in schoolchildren
  8. Effect of metformin on clinical and biochemical hyperandrogenism in adolescent girls with type 1 diabetes
  9. Obesity-related thyroiditis in childhood: relationship with insulin resistance
  10. An isolated Xp deletion is linked to autoimmune diseases in Turner syndrome
  11. Non-invasive assessment of aortic stiffness and blood pressure in young Turner syndrome patients
  12. High frequency of non-classical congenital adrenal hyperplasia form among children with persistently elevated levels of 17-hydroxyprogesterone after newborn screening
  13. The “combined team” transition clinic model in endocrinology results in high adherence rates and patient satisfaction
  14. Utilizing health information technology to improve the recognition and management of life-threatening adrenal crisis in the pediatric emergency department: medical alert identification in the 21st century
  15. Testicular adrenal rest tumors in patients with congenital adrenal hyperplasia: 6 years of follow-up
  16. Letter to the Editor
  17. Growth failure in infancy and early adiposity rebound
  18. Short Communication
  19. Clinical utility of stimulation tests in infants with suspected adrenal insufficiency (AI)
  20. Case Reports
  21. Two siblings with Gaucher type 3c: different clinical presentations
  22. Acquired partial lipodystrophy with metabolic disease in children following hematopoietic stem cell transplantation: a report of two cases and a review of the literature
  23. Therapeutic challenges in a patient with the simple virilizing (SV) form of congenital adrenal hyperplasia (CAH) due to the P30L/I172N genotype
Downloaded on 16.10.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jpem-2018-0512/html
Scroll to top button